Plasma Extracellular Vesicles as Liquid Biopsies for Glioblastoma: Biomarkers, Subpopulation Enrichment, and Clinical Translation
International Journal of Molecular Sciences · 02.12.2025 · 26 (23) · 11686
DOI: 10.3390/ijms262311686 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.12.2025. Verfasst von Abudumijiti Aibaidula und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55…. Hauptthemen laut MEDLINE: Glioblastoma, Extracellular Vesicles, Biomarkers, Tumor, Brain Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glioblastoma (GBM), the most common primary malignant brain tumor in adults, has a median survival of 14–15 months despite aggressive treatment. Monitoring relies on MRI, but differentiating tumor progression from pseudo-progression or radiation necrosis remains difficult. Plasma extracellular vesicles (EVs) are emerging as promising non-invasive biomarkers due to their molecular cargos and accessibility. This review evaluates studies that specifically isolated plasma EVs for molecular profiling in GBM diagnosis and monitoring. Biomarkers (miRNA, RNA, DNA, proteins), EV characterization methods, and advancements in enriching tumor-derived EV subpopulations and assessing their diagnostic and prognostic potential are highlighted. Plasma EVs carry diverse cargos, including miRNAs (e.g., miR-21, miR-15b-3p), mRNAs (e.g., EGFRvIII), circRNAs, and proteins (e.g., CD44, GFAP). Composite molecular signatures have achieved sensitivities of 87–100% and specificities of 73–100% for GBM diagnosis. Tumor-derived EVs, enriched using techniques like SEC-CD44 immunoprecipitation, microfluidic platforms, or 5-ALA-induced PpIX fluorescence, enhance biomarker detection. Non-tumor-derived EVs may also reflect GBM’s systemic effects. Challenges include EV heterogeneity, non-EV contamination, and variable biomarker expression across studies. Plasma-EV-based liquid biopsies offer significant potential for GBM monitoring, with advanced enrichment methods improving tumor-specific biomarker detection. Standardizing isolation protocols and validating biomarkers in larger cohorts are critical for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55901, USA.
- Department of Neurological Surgery, Mayo Clinic, Rochester, MN 55901, USA.
- Mayo Clinic Aix School of Medicine, Mayo Clinic, Rochester, MN 55901, USA.
- Department of Immunology, Mayo Clinic, Rochester, MN 55901, USA.
- Department of Urology, Mayo Clinic, Rochester, MN 55901, USA.
ORCID-Profile: Ali Gharibi Loron, Hyo Bin You, Fabrice Lucien, Ian F Parney
Zitieren
APA
Aibaidula, A., Gharibi Loron, A., Bouchal, S. M., Bauman, M. M. J., You, H. B., Lucien, F., & Parney, I. F. (2025). Plasma Extracellular Vesicles as Liquid Biopsies for Glioblastoma: Biomarkers, Subpopulation Enrichment, and Clinical Translation. International Journal of Molecular Sciences, 26(23), 11686. https://doi.org/10.3390/ijms262311686
Vancouver
Aibaidula A, Gharibi Loron A, Bouchal SM, Bauman MMJ, You HB, Lucien F, et al. Plasma Extracellular Vesicles as Liquid Biopsies for Glioblastoma: Biomarkers, Subpopulation Enrichment, and Clinical Translation. International Journal of Molecular Sciences. 2025;26(23):11686. doi:10.3390/ijms262311686
BibTeX
@article{Aibaidula2025,
author = {Aibaidula, Abudumijiti and Gharibi Loron, Ali and Bouchal, Samantha M and Bauman, Megan M J and You, Hyo Bin and Lucien, Fabrice and Parney, Ian F},
title = {Plasma Extracellular Vesicles as Liquid Biopsies for Glioblastoma: Biomarkers, Subpopulation Enrichment, and Clinical Translation},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {23},
pages = {11686},
doi = {10.3390/ijms262311686}
}
EUVIMED